-transparent.png){kind=logo}
The lithium RBC/plasma ratio was determined in 59 patients during prophylactic lithium therapy. No relationship was found between the lithium RBC/plasma ratio and sex, age, type of illness, weight, lithium dosage, duration of treatment or lithium plasma level. However, patients taking a combination of lithium and neuroleptic drugs had significantly higher lithium RBC/plasma ratios than patients taking lithium without neuroleptic drugs. The results are in line with earlier in vitro studies and are discussed in relation to the high frequency of neurotoxic and nephrotoxic adverse effects noted in patients taking a combination of lithium and neuroleptic drugs.
Related Publications
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
August 1978,
The American journal of psychiatry,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
January 1982,
Progress in neuro-psychopharmacology & biological psychiatry,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
February 1996,
Journal of clinical pharmacy and therapeutics,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
July 1986,
The American journal of psychiatry,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
January 1976,
Neuropsychobiology,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
November 1977,
Der Nervenarzt,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
September 1989,
Biological psychiatry,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
March 1976,
Pharmakopsychiatrie, Neuro-Psychopharmakologie,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
June 1989,
Biological psychiatry,
L von Knorring, and
L Smigan, and
C Perris, and
L Oreland
July 1989,
Psychiatry research,
